Mr. Mayron brings with him decades of extensive experience in the biomedical industry in Israel and abroad, including proven expertise in leading international companies, managing complex organizations, formulating growth strategies, business development, and entering new markets. His senior positions at Teva, and particularly his tenure as CEO of Teva Israel, position him as one of the most experienced and influential figures in the industry.
Lori Confino is a well-known and highly respected attorney in the hi-tech and biotech industries. Maintaining a clear view of all the shades and nuances that make up this complex world, Lori brings practical business sense to corporate and commercial transactions. Lori has over three decades of experience in corporate and commercial transactions with an emphasis on venture capital and private equity investment transactions, alongside extensive expertise guiding and advising entrepreneurs and early-stage start-ups from first seed financing, via a full range of day-to-day legal services through to the acquisition, merger or initial public offering and beyond.
Neomi Enoch, CPA, MBA Neomi is a business consultant, bringing a vast experience as a CFO in global companies traded at NASDAQ and Tel Aviv stock exchange.
Neomi led the IPO of Parter communication at NASDAQ, and The IPO of Mul-T-Lock in Tel Aviv Stock Exchange and raised funds from capital market as CFO of Meuhedet HMO and Supesal Ltd.
Neomi serves as a director at Mekorot Water Company, Kalil industries Ltd, Exel solutions group and S.R. Accord Ltd
Neomi is a CPA holds an M.B.A from Bradford University, cum laud and B.A from Tel Aviv University.
Stanley Hirsch is a biotech and pharma CEO and Board Director with significant experience across biopharmaceutical and agricultural biotech fields. He has extensive executive and board level experience in private and publicly listed companies on US and UK exchanges, direct experience raising capital and leading Mergers & Acquisitions.
With over 25 years of experience in medical operations and biotech, previously with LBT Laser Beam Therapeutics, he holds a Ph.D. in Health Systems Management from Ben-Gurion University.
A pioneer in regenerative medicine, trained at MIT under Prof. Robert Langer. He founded Tel Aviv University’s Tissue Engineering Lab and leads research in nanotechnology-based tissue regeneration.
An award-winning researcher and recipient of the Young and Promising Bio-Medical Researcher Rappaport Prize (2018), the Juludan Foundation Research Award (2018), and the Da Vinci Award (2023).